NCT00600496 2025-11-13A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)AstraZenecaPhase 1 Active not recruiting140 enrolled
NCT00014456 2013-08-28Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsDartmouth-Hitchcock Medical CenterPhase 1 Completed35 enrolled